Motley Fool Premium
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

These were the best performers on the FTSE 100 in January

| Ben McPoland

The FTSE 100 might have got off to a slow start this year, but these top-performing stocks certainly didn't. Why…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

I reckon this FTSE 100 stock, around 35% below its high, is cheap and growing fast!

| Oliver Rodzianko

Our writer has found a FTSE 100 company that he thinks has top-class margins and revenue growth rates at an…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Can this FTSE 100 stock grow 2x in 2 years?

| Dr. James Fox

The FTSE-listed generic manufacturer has been overlooked by many since joining the blue-chip index. Dr James Fox takes a closer…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Is the Hikma Pharmaceuticals share price becoming cheap?

| Dr. James Fox

The Hikma Pharmaceuticals share price dipped after a trading update on Thursday 2 November. Dr James Fox explores whether this…

Read more »

Man thinking about artificial intelligence investing algorithms
Investing Articles

Is this FTSE pharma stock a no-brainer buy?

| Sumayya Mansoor

Our writer takes a closer look at this FTSE pharmaceutical business and decides whether or not it could be a…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I’d buy 2,430 shares of this stock for £100 in monthly passive income

| Zaven Boyrazian, CFA

Zaven Boyrazian explores one recovering healthcare company with a small yield and the potential to propel dividends to new heights…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

2 UK dividend stocks I’d buy today

| Kevin Godbold

I think the growing stream of income from these two UK dividend stocks would sit well in my diversified portfolio…

Read more »

Young female analyst working at her desk in the office
Investing Articles

2 stocks ready to bounce back

| Kevin Godbold

The stock market is full of recovering stocks and I think these two look set to move higher driven by…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

The FTSE 100 is near its lowest in a year! I’d buy these shares now

| Zaven Boyrazian, CFA

With the FTSE 100 trading near its lowest point, I could be looking at some of the best buying opportunities…

Read more »

Black father holding daughter in a field of cows
Investing Articles

Best British shares to buy in September

| The Motley Fool Staff

We asked our writers to share their ‘best of British’ stocks to buy this month, including defensive plays and distributors…

Read more »

Investing Articles

FTSE 100 reshuffle: 2 shares I’d buy in September

| Roland Head

Next week's FTSE 100 reshuffle could see some big names relegated to the FTSE 250. Roland Head has spotted two…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

What are the top FTSE 100 dividend shares to buy now?

| Zaven Boyrazian, CFA

FTSE 100 dividend shares continue to reward investors, but which are the best to buy now? Zaven Boyrazian investigates.

Read more »